# Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

> **NCT02311010** · PHASE4 · UNKNOWN · sponsor: **Université Catholique de Louvain** · enrollment: 150 (estimated)

## Conditions studied

- Kidney Diseases

## Interventions

- **DRUG:** Advagraf

## Key facts

- **NCT ID:** NCT02311010
- **Lead sponsor:** Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2014-10
- **Final completion:** 2015-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2014-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311010, "Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02311010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*